Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma

por Li, Peng, Liu, Hongliang, Zhang, Zhiqiang, Lv, Xiaodong, Wang, Huijuan, Ma, Jie, Ma, Zhiyong, Qu, Xiujuan, Teng, Yue-e
Publicado 2018

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

por Wang, Qian, Cheng, Yu, Wang, Yan, Fan, Yibo, Li, Ce, Zhang, Ye, Wang, Yiding, Dong, Qian, Ma, Yanju, Teng, Yue-e, Qu, Xiujuan, Liu, Yunpeng
Publicado 2017

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer

por Xin, Xing, Wen, Ti, Gong, Li-Bao, Deng, Ming-Ming, Hou, Ke-Zuo, Xu, Lu, Shi, Sha, Qu, Xiu-Juan, Liu, Yun-Peng, Che, Xiao-Fang, Teng, Yue-E
Publicado 2020

Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer

por Qu, Jing-lei, Li, Xin, Qu, Xiu-juan, Zhu, Zhi-tu, Zhou, Li-zhong, Teng, Yue-e, Zhang, Jing-dong, Jin, Bo, Zhao, Ming-fang, Yu, Ping, Liu, Yun-peng
Publicado 2013

FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis

por Xu, Lu, Shen, Ji-Ming, Qu, Jing-Lei, Song, Na, Che, Xiao-Fang, Hou, Ke-Zuo, Shi, Jing, Zhao, Lei, Shi, Sha, Liu, Yun-Peng, Qu, Xiu-Juan, Teng, Yue-E
Publicado 2021

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equiv...

por Xu, Binghe, Zhang, Qingyuan, Sun, Tao, Li, Wei, Teng, Yue’e, Hu, Xichun, Bondarenko, Igor, Adamchuk, Hryhoriy, Zhang, Liangming, Trukhin, Dmytro, Wang, Shusen, Zheng, Hong, Tong, Zhongsheng, Shparyk, Yaroslav, Wang, Qingyu
Publicado 2021

Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis

por Xu, Lu, Qu, Jing-Lei, Song, Na, Zhang, Ling-Yun, Zeng, Xue, Che, Xiao-Fang, Hou, Ke-Zuo, Shi, Sha, Feng, Zu-Ying, Qu, Xiu-Juan, Liu, Yun-Peng, Teng, Yue-E
Publicado 2020

Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer

por Qu, Jing-lei, Qu, Xiu-juan, Li, Zhi, Zhang, Jing-dong, Liu, Jing, Teng, Yue-e, Jin, Bo, Zhao, Ming-fang, Yu, Ping, Shi, Jing, Fu, Ling-yu, Wang, Zhen-ning, Liu, Yun-peng
Publicado 2015

A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer

por Wang, Biyun, Sun, Tao, Zhao, Yannan, Wang, Shusen, Zhang, Jian, Wang, Zhonghua, Teng, Yue-E, Cai, Li, Yan, Min, Wang, Xiaojia, Jiang, Zefei, Pan, Yueyin, Luo, Jianfeng, Shao, Zhimin, Wu, Jiong, Guo, Xiaomao, Hu, Xichun
Publicado 2022

YY1 suppresses FEN1 over-expression and drug resistance in breast cancer

por Wang, Jianwei, Zhou, Lina, Li, Zhi, Zhang, Ting, Liu, Wenpeng, Liu, Zheng, Yuan, Yate-Ching, Su, Fan, Xu, Lu, Wang, Yan, Zhou, Xiaotong, Xu, Hong, Hua, Yuejin, Wang, Ying-Jie, Zheng, Li, Teng, Yue-E, Shen, Binghui
Publicado 2015

Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China

por Yang, Huan, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E, Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E, Fan, Jin-Hu, Wang, Jia-Yu, Qiao, You-Lin, Xu, Bing-He
Publicado 2022

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

por Fan, Jin-Hu, Zhang, Su, Yang, Huan, Yi, Zong-Bi, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Wang, Jia-Yu, Xu, Bing-He, Qiao, You-Lin
Publicado 2023

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

por Han, Yi-Qun, Yi, Zong-Bi, Yu, Pei, Wang, Wen-Na, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Qiao, You-Lin, Fan, Jin-Hu, Wang, Jia-Yu, Xu, Bing-He
Publicado 2021